Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

LANGaware Forges Transformative Collaboration With Premier, Inc.’s PINC AI Applied Sciences (PAS) to Revolutionize Healthcare

Real-world data to support early patient identification for patients with neurodegenerative and behavioral health diseases.

LANGaware, an innovative leader in digital cognitive and behavioral health diagnostics, is announcing that it will partner with Premier’s PINC AI Applied Sciences (PAS) to leverage Real-World Data (RWD) for the development of novel therapeutics addressing neurodegenerative and behavioral health diseases.

PAS, renowned for its robust data gleaned from over 4,350 hospitals and 300,000 continuum-of-care providers nationwide, will provide expertise in conducting prospective research utilizing retrospective synthetic arms built from the PINC AI™ Healthcare Database (PHD).

Recommended AI News: Riding on the Generative AI Hype, CDP Needs a New Definition in 2024

“Neurodegenerative diseases like Alzheimer’s and Parkinson’s and behavioral health conditions such as depression affect millions of people worldwide,” said Denise Juliano, Group Vice President of Life Sciences at PINC AI™ Applied Sciences. “The PAS-LANGaware partnership will enable RWD that supports early patient identification and detection – and drives evidence-based decisions by clinicians to improve quality, lower costs, reduce risk and help ensure safety for these patients.”

Related Posts
1 of 40,088

Recommended AI News: Honeywell Transforms Building Management With First-Of-Its-Kind Technology

LANGaware, known for its AI-driven precision in early detection, aims to extend the availability of its platform to individuals, health systems and life science companies. Through unique voice and language biomarkers, LANGaware’s technology reduces the likelihood of false positives and unnecessary treatments.

“We are thrilled to partner with PAS and extend the reach of our digital assessment tool to more patients, health systems and life science companies,” said Vassiliki Rentoumi, Founder and CEO of LANGaware. “Our goal is to revolutionize early detection of cognitive and mental health diseases, supporting novel therapy development as well as earlier intervention by providers, to improve patient outcomes and drive positive changes in the healthcare industry. We are actively seeking partners that share our commitment to transforming patient care.”

Recommended AI News:  NowVertical Secures Brazilian Government Contracts in Data Analytics

The collaboration signifies a significant step forward in expanding access to advanced diagnostic services across the United States. By combining PAS’ extensive network of health systems and PINC AI’s RWD capabilities with LANGaware’s cutting-edge technology, the partnership aims to revolutionize healthcare by driving innovation in early detection and treatment.

[To share your insights with us as part of editorial or sponsored content, please write to]

Comments are closed.